Related Experiment Video
Updated: Dec 29, 2025

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
Association between cytokines and two circulating micro-RNAs and development of premature ventricular
Behshid Ghadrdoost1,2, Nahid Aboutaleb3, Mahin Nikougoftar Zarif4
1Physiology Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Objectives:
Recent progress in understanding the pathogenesis of premature ventricular contraction (PVC)-induced cardiomyopathy (PIC) has suggested a key role for inflammation. The aim of this study was to evaluate the expression of messenger RNAs (mRNAs) and the protein production of interleukin-6 (IL-6), IL-10, tumor necrosis factor alpha (TNF-α) and interferon-γ (IFN-γ) and two circulating micro-RNAs related to inflammation and cardiovascular disease; miR-155 and miR-146.
Materials And Methods:
The study population was comprised 25 patients with PIC and 25 patients with normal left ventricular ejection fraction despite frequent PVCs. TNF-α, IL-6, IL10, and IFN-γ levels were evaluated in peripheral blood mononuclear cells (PBMCs) by flow cytometry and their mRNAs were assessed by real time PCR. We analyzed circulating levels of these cytokines by enzyme linked immunosorbent assay (ELISA). Two circulating micro-RNAs, miR-155 and miR-146a, were also investigated.
Results:
The flow cytometry findings showed that the median fluorescence intensity (MFI) of antibodies reacted with the IL-6 and TNF-α were higher in PIC group than the control group (P-value<0.001). In ELISA, the levels of IL-6 (P-value<0.001) and TNF-α (P-value <0.001) and in RT-PCR the relative expression levels of IL-6 (P-value<0.001) and TNF-α (P-value<0.001) were significantly higher in the PIC group. The relative expression levels of miR-155 and miR-146a were not significantly different between 2 groups (P-value>0.05).
Conclusion:
In our patients with PIC, there was an elevation in the expression levels of IL-6 and TNF-α in PBMCs. This finding may provide further insights into the inflammatory pathways involved in PIC.
Insights
Inflammation plays a key role in premature ventricular contraction (PVC)-induced cardiomyopathy (PIC). Studies show elevated levels of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) in patients with PIC, suggesting their involvement in the disease.
Area of Science:
- Cardiology
- Immunology
- Molecular Biology
Background:
- Premature ventricular contraction (PVC)-induced cardiomyopathy (PIC) is a condition where frequent PVCs lead to heart muscle dysfunction.
- Inflammation is increasingly recognized as a significant factor in the development and progression of PIC.
Purpose of the Study:
- To investigate the expression of key inflammatory markers, including interleukin-6 (IL-6), IL-10, tumor necrosis factor alpha (TNF-α), and interferon-γ (IFN-γ).
- To evaluate the levels of two specific micro-RNAs, miR-155 and miR-146a, associated with inflammation and cardiovascular disease in patients with PIC.
Main Methods:
- The study included 25 patients with PIC and 25 controls with normal left ventricular ejection fraction.
- Inflammatory cytokine and micro-RNA levels were assessed in peripheral blood mononuclear cells (PBMCs) and serum using flow cytometry, real-time PCR, and ELISA.
Main Results:
- Patients with PIC exhibited significantly higher protein and mRNA expression levels of IL-6 and TNF-α in PBMCs compared to the control group.
- Circulating levels of IL-6 and TNF-α were also significantly elevated in the PIC group.
- No significant differences in the expression of miR-155 and miR-146a were observed between the two groups.
Conclusions:
- Elevated expression of IL-6 and TNF-α in PBMCs of patients with PIC supports their role in the inflammatory pathways underlying this condition.
- These findings contribute to a better understanding of the pathogenesis of PVC-induced cardiomyopathy.
Related Concept Videos
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
MicroRNAs
MicroRNAs
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

